A Step Change In Pharmaceutical Glass Packaging Innovation

As the pharmaceutical industry continues to see incredible advances in the development of new therapies, as well as in manufacturing technologies and processes, the need for innovation in pharmaceutical glass packaging is growing to ensure the safety and quality of these complex molecules.

Historically, the industry used borosilicate glass compositions for sterile injectables due to their hydrolytic performance. But, the borosilicate glasses used for the last 100 years have been the source of numerous issues. Glass delamination – the appearance of visible flakes or glass lamellae – has contributed to regulatory recalls. Beyond patient risk, delamination can be costly for pharmaceutical manufacturers.

To reduce the chance of the associated costly consequences, Corning developed Valor® Glass, a revolutionary, new aluminosilicate glass composition, developed specifically for pharmaceutical use to eliminate delamination. Corning glass scientists’ analysis found that the risk of delamination cannot be eliminated if the glass formulation contains boron, and the aluminosilicate formulation eliminates delamination when compared to borosilicate.

Valor Glass represents a significant, and much needed, step forward for glass innovation. Review the findings and learn how an aluminosilicate formulation can lower your glass vials' extractables profile.